Prepregnancy Cardiovascular Health
Definition
Prepregnancy cardiovascular health (CVH) refers to the cardiovascular risk factor profile of reproductive-age individuals measured before conception, assessed using the American Heart Association's Life's Essential 8 construct (diet, physical activity, sleep, smoking status, BMI, blood pressure, non-HDL cholesterol, fasting glucose). The prepregnancy period — including the interpregnancy interval between pregnancies — is recognized as a critical and underutilized window for CVH optimization because biological processes underlying adverse pregnancy outcomes (APOs) begin before conception and because interventions focused solely during pregnancy may have limited impact.
Key Concepts
Prevalence of Unfavorable Prepregnancy CVH
- Fewer than 1% of reproductive-age individuals have ideal levels of all CVH metrics; mean LE8 score in women is 68.1/100 sources/prepregnancy-aha-2023 (rating: high)
- Fewer than half of birthing individuals have favorable prepregnancy CVH even by abbreviated metrics (absence of obesity, hypertension, diabetes, smoking)
- Prepregnancy CVH declined 2011–2019 across all subgroups (race/ethnicity, geography, socioeconomic status) sources/prepregnancy-aha-2023 (rating: high)
- CVH metrics are highly correlated between the prepregnancy period and pregnancy — unfavorable prepregnancy CVH persists into and shapes pregnancy risk
Association with Adverse Pregnancy Outcomes
- Graded, consistent dose-response: adjusted RR for preterm birth with 1, 2, 3, or 4 poor CVH metrics (obesity/hypertension/diabetes/smoking): 1.15, 1.62, 2.85, 3.89 vs no poor metrics sources/prepregnancy-aha-2023 (rating: high)
- All individual LE8 metrics (diet, activity, sleep, BMI, BP, lipids, glycemia) independently associate with APOs — no single metric drives the association; composite CVH matters
- Obesity population attributable fraction for HDP: 26.5–30.3%; per 1 kg/m² inter-pregnancy BMI increase → OR 1.31 for HDP (meta-analysis) sources/prepregnancy-aha-2023 (rating: high)
- CHAP trial: treating mild chronic hypertension from early pregnancy reduced preterm birth, SGA, and preeclampsia; suggests prepregnancy BP optimization likely beneficial
Intergenerational Transmission
- Preterm birth → 53% higher adjusted hazards for premature ischemic heart disease by age 43 in offspring sources/prepregnancy-aha-2023 (rating: high)
- Prepregnancy T2DM → AHR 1.39 (95% CI 1.23–1.57) for offspring premature CVD by age 40 (registry study)
- Prepregnancy BMI more strongly associated with both APOs and offspring CV risk factors in adolescence than gestational weight gain, suggesting periconceptional exposure is the critical driver
- Mechanism: epigenetic reprogramming during periconceptional window links maternal metabolic status to placental and embryonic gene expression programs
Pathophysiology
- Periconceptional period is uniquely vulnerable: oocyte maturation, fertilization, embryonic genome transition, and implantation all occur; global epigenetic reorganization determines lineage-specific gene expression and metabolic controls
- Maternal obesity → follicular fluid and oocyte lipid enrichment → endoplasmic reticulum stress, increased ROS, mitochondrial dysfunction in oocyte/zygote
- Placental malperfusion secondary to inappropriate spiral artery remodeling begins long before clinical APO manifestations; affected by preexisting CVD risk factors via angiogenesis and inflammation pathways
- APOs may represent "unmasking" of preexisting CVD risk under the physiological stress of pregnancy; pre-pregnancy vascular dysfunction markers (↓arterial compliance, retinal microvascular constriction, diastolic dysfunction) predict APO risk
Intervention Evidence
- No large RCTs have tested comprehensive prepregnancy CVH interventions on maternal or offspring outcomes sources/prepregnancy-aha-2023 (rating: high)
- Bariatric surgery pre-pregnancy: substantial GDM/HDP reduction (OR 0.21 and 0.38) but with increased SGA risk (OR 2.18) — net benefit uncertain
- Postpartum lifestyle interventions modestly improve CVH; 6-year follow-up in 2 small studies suggests maternal cardiometabolic benefit and possible offspring LV structural benefit, but conflicting findings
- Hydrophilic statins (pravastatin) may be safe in pregnancy and reduce APO risk — growing consensus but unproven
- PICOTS trial framework outlined: age 25–44, overweight/intermediate risk factors, 5-year pragmatic trial in community health centers with maternal + offspring composite outcomes
Multilevel Intervention Framework
- Individual: lifestyle coaching, stress reduction, sleep interventions, weight loss pharmacotherapy/bariatric surgery, pharmacotherapy safe during pregnancy
- Community: civic engagement, peer-led support groups, place-based programs (hair salons, churches, public housing), community health workers/promotoras
- Policy: dismantle structural racism, fair housing, equitable employment and education, continuous health insurance coverage, expanded access to fertility/preconception services
- Digital health (apps, conversational agents, social marketing) may increase reach, particularly for low-socioeconomic-status individuals with barriers to in-person care
- ~50% of pregnancies are unintended — population-level and policy interventions essential, as individual-level prepregnancy interventions cannot reach this group
Contradictions / Open Questions
- Causality unproven: whether CVH → APOs → CVD is a causal chain or epiphenomenon remains unresolved; direct mechanistic evidence in humans is limited; this has major implications for trial design sources/prepregnancy-aha-2023 (rating: high)
- Metric prioritization unknown: which specific LE8 metrics are most salient to target in the prepregnancy period to optimally reduce APOs is not established
- BP thresholds: whether treatment thresholds should be lower for pregnancy-capable individuals (e.g., goal <130/80 vs <140/90 before pregnancy) is unanswered
- Bariatric surgery trade-off: reduces HDP/GDM but increases SGA risk — net maternal-offspring benefit unresolved
- Interpregnancy window: whether interventions in the postpartum/interpregnancy period improve outcomes of subsequent pregnancy is unknown
Connections
- Related to concepts/Adverse-Pregnancy-Outcomes — APOs are the primary outcomes of interest
- Related to concepts/Lifes-Essential-8 — measurement framework applied to prepregnancy period
- Related to entities/Maternal-Health-Disparities — non-Hispanic Black women disproportionately carry poor prepregnancy CVH
- Related to concepts/ASCVD-Risk-Assessment — life-course and primordial prevention framework
- Related to concepts/LQTS-Pregnancy-Management — pregnancy management in inherited arrhythmia; overlapping maternal CVH context